| 体内研究: |
EMD638683 处理小鼠的结肠明显更长,结肠重量明显低于安慰剂处理小鼠,这一发现表明 EMD638683 对化学致癌作用后的肿瘤生长有影响。此外,EMD 处理组的胃重量显著降低。最重要的是,通过 EMD638683 处理,显著减少了致癌处理后发展为肿瘤的数量。 EMD638683 (20 mg/kg,灌胃) 防止野百合碱 (MCT) 诱导的大鼠肺血管重塑的进展。血液动力学特征显示,EMD638683 处理可降低右心室收缩压 (RVSP) (15.8 vs. 28.2 mmHg;P<0.05;n=6) 和右心室肥厚指数 (RVHI) (0.27 vs. 0.41);P<0.05;n=6) 与对照剂量控制相比。 |
| 参考文献: |
1. Ackermann TF, et al. EMD638683, a novel SGK inhibitor with antihypertensive potency. Cell Physiol Biochem. 2011;28(1):137-46. 2. Towhid ST, et al. Inhibition of colonic tumor growth by the selective SGK inhibitor EMD638683. Cell Physiol Biochem. 2013;32(4):838-48. 3. Xi X, et al. Serum-glucocorticoid regulated kinase 1 regulates macrophage recruitment and activation contributing to monocrotaline-induced pulmonary arterial hypertension. Cardiovasc Toxicol. 2014 Dec;14(4):368-78. 4. Zhou H, et al. Inhibition of serum- and glucocorticoid-inducible kinase 1 enhances TLR-mediated inflammation and promotes endotoxin-driven organ failure. FASEB J. 2015 Sep;29(9):3737-49. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.745 ml |
13.723 ml |
27.447 ml |
| 5 mM |
0.549 ml |
2.745 ml |
5.489 ml |
| 10 mM |
0.274 ml |
1.372 ml |
2.745 ml |
| 50 mM |
0.055 ml |
0.274 ml |
0.549 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |